EP 1487495 A1 20041222 - COMBINATION COMPRISING A CDK INHIBITOR AND DOXORUBICIN
Title (en)
COMBINATION COMPRISING A CDK INHIBITOR AND DOXORUBICIN
Title (de)
KOMBINATION ENTHALTEND EINEN CDK INHIBITOR UND DOXORUBICIN
Title (fr)
COMBINAISON COMPRENANT UN INHIBITEUR DE CDK ET DE LA DOXORUBICINE
Publication
Application
Priority
- GB 0301282 W 20030325
- GB 0207228 A 20020327
- GB 0222408 A 20020926
- GB 0225876 A 20021106
Abstract (en)
[origin: WO03082337A1] A first aspect of the invention relates to a combination comprising a CDK inhibitor and doxorubicin. A second aspect of the invention relates to a pharmaceutical product comprising a CDK inhibitor and doxorubicin as a combined preparation for simultaneous, sequential or separate use in therapy. A third aspect of the invention relates to a method of treating a proliferative disorder, said method comprising simultaneously, sequentially or separately administering a CDK inhibitor and doxorubicin to a subject.
IPC 1-7
IPC 8 full level
A61K 45/00 (2006.01); A61K 31/52 (2006.01); A61K 31/704 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/704 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2017.12); Y02A 50/30 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 03082337A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03082337 A1 20031009; AU 2003217024 A1 20031013; BR 0308756 A 20041228; CN 1655821 A 20050817; EP 1487495 A1 20041222; JP 2005527560 A 20050915; MX PA04009396 A 20050125
DOCDB simple family (application)
GB 0301282 W 20030325; AU 2003217024 A 20030325; BR 0308756 A 20030325; CN 03812085 A 20030325; EP 03712412 A 20030325; JP 2003579873 A 20030325; MX PA04009396 A 20030325